Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
1997-8-7
|
pubmed:abstractText |
Dendritic cells (DCs) are professional antigen-presenting cells that process and present antigenic peptides and are capable of generating potent T-cell immunity. A murine tumor model was developed to evaluate methods of genetic immunization to the human MART-1/Melan-A (MART-1) melanoma antigen. A poorly immunogenic murine fibrosarcoma line (NFSA) was stably transfected with the MART-1 gene. This transfected tumor [NFSA(MART1)] grows progressively in C3Hf/Kam/Sed (H-2k) mice. Partial protection against a challenge with NFSA(MART1) could be achieved with i.m. injections of a MART-1 expression plasmid or with systemic administration of an adenovirus vector expressing MART-1. However, superior protection was achieved when granulocyte macrophage colony-stimulating factor/interleukin-4-differentiated murine DCs transduced with an adenovirus vector expressing MART-1 were used for immunization. Both partial and complete protection could be achieved with i.v. administration of MART-1-engineered DCs. Splenocytes from immunized mice contained MHC class 1-restricted CTLs specific for MART-1. This preclinical model of genetic immunization supports a therapeutic strategy for human melanoma.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/MART-1 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/MLANA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mlana protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-5472
|
pubmed:author |
pubmed-author:ButterfieldL HLH,
pubmed-author:ChenA YAY,
pubmed-author:DissetteV BVB,
pubmed-author:EconomouJ SJS,
pubmed-author:ElyJ SJS,
pubmed-author:GlaspyJ AJA,
pubmed-author:JilaniS MSM,
pubmed-author:LawG RGR,
pubmed-author:LawPP,
pubmed-author:McBrideW HWH,
pubmed-author:RibasAA,
pubmed-author:VollmerC MCM
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2865-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9230191-Adenoviridae,
pubmed-meshheading:9230191-Animals,
pubmed-meshheading:9230191-Antigens, Neoplasm,
pubmed-meshheading:9230191-Dendritic Cells,
pubmed-meshheading:9230191-Female,
pubmed-meshheading:9230191-Gene Therapy,
pubmed-meshheading:9230191-Humans,
pubmed-meshheading:9230191-Immunization,
pubmed-meshheading:9230191-MART-1 Antigen,
pubmed-meshheading:9230191-Mice,
pubmed-meshheading:9230191-Mice, Inbred C3H,
pubmed-meshheading:9230191-Neoplasm Proteins,
pubmed-meshheading:9230191-Neoplasms,
pubmed-meshheading:9230191-Transfection
|
pubmed:year |
1997
|
pubmed:articleTitle |
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.
|
pubmed:affiliation |
Division of Surgical Oncology, University of California Los Angeles Medical Center, 90024, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|